Vaccine
Safety, immunogenicity, and lot consistency of a 13-valent pneumococcal conjugate vaccine in Chinese children aged 2-5 years: A phase III study.
Liwei Shi, Jingjing Chen, Hong Li, Xuemei Yan, Fang Shen, Xin Lai, Lin Yuan, Yi Mo
Published: 202610.1016/j.vaccine.2026.128244
Abstract
BACKGROUND: Pneumococcal conjugate vaccines have significantly reduced the global morbidity and mortality burdens of pneumococcal disease in children under five years of age, but supply constraints remain. We evaluated the safety, immunogenicity, and…
Preview only. Read the full abstract at the source